
Circumvent
Circumvent is a YC Summer 2018 (S18) company. Team of 6.
About Circumvent
Summary
Circumvent develops precision medicines for neurodegenerative diseases, starting with Batten Disease, a rare fatal disorder. Research into Batten Disease has surfaced mechanistic insights into synaptic function, protein localization, lysosomal activity, and the palmitoylome, a set of lipid-modified proteins central to brain-cell health. Circumvent applies these findings across both rare and common neurodegenerative conditions, replacing the field's reliance on low-fidelity disease models with genetically defined, high-predictivity biology.
From the Y Combinator listing
Utilizing monogenic disorders to inform and solve highly complex…
Facts
- Healthcare / Healthcare -> Therapeutics
- 6
- Active
- Early
Founders (1)
- Devin Wiley
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works